GL1X · GenesisL1 explorer

Research workbench

Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures

Analyse Design of P1' and P3' residues of trivalent thrombin inhibitors and their… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1EOJ
Type
protein
Length
291 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha thrombin; Thrombin inhibitor P798
EC
3.4.21.5
UniProt
P00734
Ligands
BBS
Pockets
1 · best druggability 0.28

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha thrombin (EC 3.4.21.5)protein27817% helix, 31% strandP00734
BThrombin inhibitor P798protein130% helix, 0% strand—

Ligands and binding sites

  • BBS · 4-tert-butylbenzenesulfonic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1610.280.7314empty

Interfaces

1 interface between chains.

  • A–B · 1100 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 3 modified, 1 covalent (disulfide, nonstandard, covalent ligand).

Compared structures

  • 1EOJ · Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.